Blue Owl Capital (NYSE:OWL) Given “Buy” Rating at TD Cowen

Blue Owl Capital (NYSE:OWL)‘s stock had its “buy” rating reaffirmed by stock analysts at TD Cowen in a research note issued on Monday,Benzinga reports. They currently have a $14.00 price objective on the stock. TD Cowen’s price objective would suggest a potential upside of 45.30% from the stock’s previous close.

A number of other brokerages also recently issued reports on OWL. Citizens Jmp lowered their price target on Blue Owl Capital from $23.00 to $21.00 and set a “market outperform” rating for the company in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft downgraded Blue Owl Capital from a “buy” rating to a “hold” rating and lowered their price target for the company from $15.00 to $10.00 in a report on Tuesday, February 24th. Citigroup reissued an “outperform” rating on shares of Blue Owl Capital in a report on Tuesday, January 27th. Weiss Ratings reissued a “hold (c)” rating on shares of Blue Owl Capital in a report on Wednesday, January 21st. Finally, UBS Group increased their price objective on Blue Owl Capital from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $15.03.

Blue Owl Capital Stock Up 1.8%

OWL traded up $0.18 on Monday, reaching $9.64. The company’s stock had a trading volume of 4,766,606 shares, compared to its average volume of 29,535,059. The stock has a 50 day moving average of $9.29 and a two-hundred day moving average of $12.60. The company has a market capitalization of $14.98 billion, a price-to-earnings ratio of 80.13, a P/E/G ratio of 1.00 and a beta of 1.19. Blue Owl Capital has a fifty-two week low of $7.95 and a fifty-two week high of $21.08.

Blue Owl Capital (NYSE:OWL) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.19 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.19. The firm had revenue of $699.88 million during the quarter, compared to the consensus estimate of $687.23 million. Blue Owl Capital had a return on equity of 21.97% and a net margin of 2.96%. As a group, analysts anticipate that Blue Owl Capital will post 0.88 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Blue Owl Capital

Several large investors have recently modified their holdings of OWL. Royal Bank of Canada raised its stake in shares of Blue Owl Capital by 50.0% during the first quarter. Royal Bank of Canada now owns 397,990 shares of the company’s stock worth $7,976,000 after purchasing an additional 132,637 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of Blue Owl Capital by 4.0% during the second quarter. Russell Investments Group Ltd. now owns 44,215 shares of the company’s stock worth $849,000 after purchasing an additional 1,703 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of Blue Owl Capital during the second quarter worth approximately $238,000. California Public Employees Retirement System raised its stake in shares of Blue Owl Capital by 28.2% during the second quarter. California Public Employees Retirement System now owns 787,255 shares of the company’s stock worth $15,123,000 after purchasing an additional 172,982 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Blue Owl Capital by 10.6% during the second quarter. State Street Corp now owns 9,880,565 shares of the company’s stock worth $189,806,000 after purchasing an additional 950,700 shares during the last quarter. Hedge funds and other institutional investors own 35.85% of the company’s stock.

About Blue Owl Capital

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.